International Benefits
We partner with an international team with over 200+ years of international underwriting and brokerage experience.
The typical mid-sized multinational HR is understaffed and with a limited understanding and experience of international benefits. We partner with an international team with over 200+ years of international underwriting and brokerage experience. Domestic and International benefits are handled together—we’re all on the same side.
Consultative Approach: Custom benefits assessments focused on the client’s specific needs and objectives.
Flexibility: Complete objectivity and commitment to address the client's needs.
Customer-Driven Programs: Every program is designed, implemented, and managed to best reflect the client's existing and future needs.
Communication: Client procedures manual coupled with an international service bulletin instructs and assists clients, on what, how and when to do it.
We help clients to:
- Understand their international benefits
- Cut/manage costs
- Control worldwide renewals
- Concerns about compliance
- Start-up operation abroad
- Considering acquisition
- Ongoing international help
Key Services
- Information / Education
- Country Profiles
- Newsletter / Updates
- Consulting Services
- Benefits Assessments
- M&A Due Diligence
- Partner Desks
- Brokerage Services
- International RFP / Marketing
- Implementation / Ongoing Service
Additional Services
- Mergers & Acquisitions
- Multinational Pooling
- Globally Pooled / Cross Border Products
- Expatriate Benefits
- "Specialty Risks"
- War & Terrorism
- International Keyman Life
- International Pensions
- Global EAP / Wellness / Wellbeing
Featured News & Insights
We’ve all heard the phrase “doctor’s orders,” from a family member or friend reminding us to eat healthy or take our medicine. But it’s not a catchphrase. The advice a doctor provides is a real plan...
As healthcare systems grow more complex, as does the complexity for consumers trying to manage and understand their benefits. Yet many of the systems designed to support them often lack clarity and...
On June 30, 2025, the U.S. Supreme Court announced its decline to review decision in Pharmaceutical Care Management Association (PCMA) v. Mulready, a ruling by the U.S. Court of Appeals for the 10th...